Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

2013; Dove Medical Press; Linguagem: Inglês

10.2147/ceor.s47990

ISSN

1178-6981

Autores

Ken O’Day, Krithika Rajagopalan, Kellie Meyer, Andrei Pikalov, A. Loebel,

Tópico(s)

Health Systems, Economic Evaluations, Quality of Life

Resumo

The purpose of this study was to evaluate the long-term cost-effectiveness (including hospitalizations and cardiometabolic consequences) of atypical antipsychotics among adults with schizophrenia.

Referência(s)